Invion

Invion (IVX)

Stock Code

IVX

Stock Exchange

Australian Securities Exchange

Invion (IVX) shares were listed on the Australian Stock Exchange on February 15, 2010 and is in the Health Care sector. INVION LIMITED is a life sciences company focussed on the development of treatments for major opportunities in inflammatory diseases, with operations in Brisbane, Australia and Delaware, USA. Invion is engaged in the completion of clinical development programs and targeted business development programs associated with its approximately three drug assets, such as INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast).

Syndicate content

Recommended Websites